These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT. Wildi SM; Gubler C; Hany T; Petrowsky H; Clavien PA; Jochum W; Gerlach T; Fried M; Mullhaupt B J Clin Ultrasound; 2008 Jan; 36(1):20-6. PubMed ID: 17937421 [TBL] [Abstract][Full Text] [Related]
3. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial. Moulton CA; Gu CS; Law CH; Tandan VR; Hart R; Quan D; Fairfull Smith RJ; Jalink DW; Husien M; Serrano PE; Hendler AL; Haider MA; Ruo L; Gulenchyn KY; Finch T; Julian JA; Levine MN; Gallinger S JAMA; 2014 May; 311(18):1863-9. PubMed ID: 24825641 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. Rydzewski B; Dehdashti F; Gordon BA; Teefey SA; Strasberg SM; Siegel BA AJR Am J Roentgenol; 2002 Feb; 178(2):353-8. PubMed ID: 11804891 [TBL] [Abstract][Full Text] [Related]
5. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241 [TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Truant S; Huglo D; Hebbar M; Ernst O; Steinling M; Pruvot FR Br J Surg; 2005 Mar; 92(3):362-9. PubMed ID: 15672427 [TBL] [Abstract][Full Text] [Related]
7. A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases. Daza JF; Solis NM; Parpia S; Gallinger S; Moulton CA; Belley-Cote EP; Levine MN; Serrano PE Eur J Surg Oncol; 2019 Aug; 45(8):1341-1348. PubMed ID: 30928334 [TBL] [Abstract][Full Text] [Related]
9. Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning? Adie S; Yip C; Chu F; Morris DL ANZ J Surg; 2009 May; 79(5):358-61. PubMed ID: 19566517 [TBL] [Abstract][Full Text] [Related]
10. Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases. Pawlik TM; Assumpcao L; Vossen JA; Buijs M; Gleisner AL; Schulick RD; Choti MA Ann Surg Oncol; 2009 Feb; 16(2):371-8. PubMed ID: 19020939 [TBL] [Abstract][Full Text] [Related]
11. Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery. Wiering B; Ruers TJ; Krabbe PF; Dekker HM; Oyen WJ Ann Surg Oncol; 2007 Feb; 14(2):818-26. PubMed ID: 17136470 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases. Glazer ES; Beaty K; Abdalla EK; Vauthey JN; Curley SA Arch Surg; 2010 Apr; 145(4):340-5; discussion 345. PubMed ID: 20404283 [TBL] [Abstract][Full Text] [Related]
13. The role of FDG-PET in the selection of patients with colorectal liver metastases. Wiering B; Krabbe PF; Dekker HM; Oyen WJ; Ruers TJ Ann Surg Oncol; 2007 Feb; 14(2):771-9. PubMed ID: 17086488 [TBL] [Abstract][Full Text] [Related]
14. Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases. Wiering B; Adang EM; van der Sijp JR; Roumen RM; de Jong KP; Comans EF; Pruim J; Dekker HM; Ruers TJ; Krabbe PF; Oyen WJ Nucl Med Commun; 2010 Nov; 31(11):938-44. PubMed ID: 20856152 [TBL] [Abstract][Full Text] [Related]
16. The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. Rohren EM; Paulson EK; Hagge R; Wong TZ; Killius J; Clavien PA; Nelson RC Clin Nucl Med; 2002 Aug; 27(8):550-5. PubMed ID: 12169999 [TBL] [Abstract][Full Text] [Related]
17. Positron Emission Tomography Combined With Computed Tomography vs. No Positron Emission Tomography Combined With Computed Tomography for the Management of Patients With Resectable Colorectal Cancer Liver Metastases and Synchronous Extrahepatic Disease. Serrano PE; Gu CS; Moulton CA; Gallinger S Am Surg; 2021 Sep; 87(9):1431-1437. PubMed ID: 33345573 [TBL] [Abstract][Full Text] [Related]
18. Impact of ¹⁸F-FDG-PET in decision making for liver metastectomy of colorectal cancer. McLeish AR; Lee ST; Byrne AJ; Scott AM ANZ J Surg; 2012; 82(1-2):30-5. PubMed ID: 22507492 [TBL] [Abstract][Full Text] [Related]
19. The evolving role of staging laparoscopy in the treatment of colorectal hepatic metastasis. Thaler K; Kanneganti S; Khajanchee Y; Wilson C; Swanstrom L; Hansen PD Arch Surg; 2005 Aug; 140(8):727-34. PubMed ID: 16103281 [TBL] [Abstract][Full Text] [Related]
20. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Boykin KN; Zibari GB; Lilien DL; McMillan RW; Aultman DF; McDonald JC Am Surg; 1999 Dec; 65(12):1183-5. PubMed ID: 10597072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]